FDA
-
-
-
-
-
-
-
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
-
-
-
-
-
-
-
US FDA declines to approve AbbVie's wrinkle treatment due to manufacturing concerns (April 23)
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Abbvie (ABBV)
-
-
-
-
-
-
-
Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight
-
-
-
-
-
-
-
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers
-
-
-
-
-
-
-
AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo
-
-
-
-
-
-
-
Aldeyra Therapeutics (ALDX) PT Raised to $7 at Jefferies
-
322,995 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

